![Charles Romp](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Romp
Direttore/Membro del Consiglio presso
CELCUITY INC.
Patrimonio netto: 182 562 $ in data 30/06/2026
Profilo
Charles R.
Romp is President, Chief Executive Officer & Director at Secura Bio, Inc. since 2024.
Mr. Romp is an Independent Director at Celcuity, Inc. starting in 2026.
Former roles include Executive Vice President-Commercial at Seagen, Inc. from 2020 to 2023, Sales Director at Avastin, Product Manager at GE Medical Systems, Inc. from 1997 to 1998, and Pharmaceutical Sales Representative at GlaxoSmithKline LLC.
Education includes an MBA from Saint Leo University, Inc. and undergraduate studies at the University of Florida.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 05/06/2026 | 1.745 ( 0% ) | 182 562 $ | 30/06/2026 |
Posizioni attive di Charles Romp
| Società | Posizione | Inizio |
|---|---|---|
| CELCUITY INC. | Direttore/Membro del Consiglio | 11/02/2026 |
Secura Bio, Inc.
 Secura Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products for oncology therapies | Amministratore Delegato | 15/10/2024 |
Precedenti posizioni note di Charles Romp
| Società | Posizione | Fine |
|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | 14/12/2023 |
GE Medical Systems, Inc.
 GE Medical Systems, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic imaging and medical monitoring systems as well as provides information technology services to health care providers | Corporate Officer/Principal | 01/01/1998 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | - |
Avastin | Vendite & Marketing | - |
Formazione di Charles Romp
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
63
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
GE Medical Systems, Inc.
GE Medical Systems, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic imaging and medical monitoring systems as well as provides information technology services to health care providers | Health Technology |
Saint Leo University, Inc.
 Saint Leo University, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Avastin | |
Celcuity, Inc.
 Celcuity, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company develops novel diagnostic tests | Health Technology |
Secura Bio, Inc.
Secura Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products for oncology therapies | Health Technology |
